FDA Inspection
Bausch & Lomb Ireland LimitedBausch & Lomb Ireland Limited – FDA Inspection, Jul 1, 2022
Record Details
This FDA Inspection record concerns Bausch & Lomb Ireland Limited, with an inspection on July 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 1, 2022
- Product Type
- Drugs
View Company Profile
ID · dcc4b56d-b01d-40b0-8bef-983a799545ec
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1179049
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bausch & Lomb Ireland Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 16, 2018 | Not classified | Office of Inspections and Investigations | |
| September 15, 2017 | Not classified | Office of Inspections and Investigations | |
| February 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 9, 2011 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 21, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch & Lomb Ireland Limited
- FDA Inspection 1102223 - 2018-11-16
- FDA Inspection 1042514 - 2017-09-15
- FDA Inspection 1008319 - 2017-02-17
- FDA Inspection 744844 - 2011-08-09
- FDA Inspection 739708 - 2011-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.